Tag Archives: Xanthones/therapeutic use

Vascular priming enhances chemotherapeutic efficacy against head and neck cancer

Folaron M, Kalmuk J, Lockwood J, Frangou C, Vokes J, Turowski SG, Merzianu M, Rigual NR, Sullivan-Nasca M, Kuriakose MA, Hicks WL, Jr., Singh AK, Seshadri M. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol. September 2013;49(9):893-902. Full Text – Open Access Publication Date September 2013 How Analyze was Used “All…

MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas

Seshadri M, Ciesielski MJ. MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas. J Cereb Blood Flow Metab. August 2009;29(8):1373-1382. Full Text – Open Access Publication Date August 2009 How Analyze was Used “After image acquisition, raw image sets were transferred to a processing workstation and converted into Analyze format (AnalyzeDirect, Version 8.0, Overland…

The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo

Seshadri M, Bellnier DA. The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo. Photochem Photobiol. January 2009;85(1):50-56. Full Text – Open Access Publication Date January 2009 How Analyze was Used “Image processing and analysis was carried out using commercially available software (Analyze PC,…